Here are the stocks added to the Zacks #5 Rank ("strong sell") List today:

American Water Works Co Inc (AWK) Amerigas Partners LP (APU) Associated Banc-Corp (ASBC) Benchmark Electronics Inc (BHE) Benihana Inc (BNHNA) BMP Sunstone Corp (BJGP) Cape Bancorp Inc (CBNJ) China Nepstar Chain Drugstore Ltd (NPD) Conmed Corp (CNMD) Crucell NV (CRXL) Duke Energy Corp (DUK) Empire District Electric Co (EDE) Emulex Corp (ELX) Encore Wire Corp (WIRE) Fair Isaac Corp (FICO) ...

Here are the stocks added to the Zacks #5 Rank ("strong sell") List today:

American Commercial Lines Inc (ACLI) Arris Group Inc (ARRS) Associated Banc-Corp (ASBC) Astec Industries Inc (ASTE) Badger Meter Inc (BMI) Banner Corp (BANR) Beacon Roofing Supply Inc (BECN) Brunswick Corp (BC) C&D Technologies Inc (CHP) Capital Product Partners LP (CPLP) Capitol Federal Financial (CFFN) Ciber Inc (CBR) CIT Group Inc (CIT) Copano Energy LLC (CPNO) Crucell NV (CRXL) CryptoLogic Ltd (CRYP) Empresa Brasileira de Aeronautica SA (ERJ) ...

It seems that the swine flu pandemic has attracted many large pharmaceutical players towards the vaccine business, the latest being Johnson & Johnson (JNJ). Yesterday, J&J acquired an 18% stake in a Netherlands-based biotech company, Crucell NV, for $440 million. The deal will primarily focus on developing a universal vaccine for influenza treatment using Crucell's genetically engineered antibody technology. Additionally, vaccines for other diseases will be developed in due course. Following the deal, J&J’s per-share earnings will be reduced by 2 cents to 4 cents in 2009. Per the deal, Crucell will retain the European marketing right for the vaccine which will be jointly produced by the companies, while Johnson & Johnson will market the vaccine in the rest of the world. Accordingly, Crucell is eligible to receive royalties on global sales. Although the vaccine influenza vaccine is still in an early stage of development, ...

Takeover Targets: 3 Steps To Finding Them & 3 Stocks For Any Portfolio

by Louis Basenese, Advisory Panelist Senior Analyst, The Oxford Club

I promise. Alexander Green and I are not in cahoots about the coming boom in corporate takeovers…

We both researched the possibility separately. Unprompted, I might add. And yet, armed with different evidence, we arrived at the same conclusion.

If you ask me, such a convergence of analysis in a narrow space of time shouldn’t be ignored. So today, let’s move on from why a takeover boom is imminent and focus exclusively on three takeover targets you can profit from…

Identifying The Market’s Next Takeover Targets

The task of identifying the market’s next takeover targets can be daunting. Literally thousands of potential targets exist, which is probably why most investors liken it to a crapshoot and in turn, shun such a strategy altogether.

But that’s a

...

Crucell NV's (CRXL) MACD indicator has crossed over to bullish territory with a reading of 0.0582. The Zacks #1 Rank ("Strong Buy") stock has advanced more than 1% to $21.03 in morning trade. The company has topped the consensus in each of the last 4 quarters with an average surprise of 154.89%, or 14 cents per share. Moreover, the full-year consensus estimate has increased by 12 cents over the past 60 days to 73 cents per share.

Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Achillion Pharmaceuticals Inc (ACHN) Advance Auto Parts Inc (AAP) Advantest Corp (ATE) Agree Realty Corp (ADC) Aluminum Corp of China Ltd (ACH) Amkor Technology Inc (AMKR) ARYx Therapeutics Inc (ARYX) Barloworld Ltd (BRRAY) Bio-Reference Laboratories Inc (BRLI) The Buckle Inc (BKE) California Pizza Kitchen Inc (CPKI) Cerus Corp (CERS) Chipotle Mexican Grill Inc (CMG.B) Coca-Cola Enterprises Inc (CCE) Crucell NV (CRXL) D R Horton Inc (DHI) Dana Holding Corp (DAN) Delhaize Group (DEG) Diageo Plc (DEO) Distribucion Y SVC (DYSVY) Emergency Medical Services Corp (EMS) Gen-Probe Inc (GPRO) Healthcare Services Group Inc (HCSG) HLS Systems International Ltd (HOLI) ICU Medical Inc (ICUI) Keppel Corporation Ltd (KPELY) L'Oreal SA (...

Crucell NV (CRXL) shares are experiencing unusually high trading volume. The company stock fell below 1% at $20.35 in the morning session.

Zacks Investment Research

Crucell N.V (...

Crucell N.V. (CRXL) climbed 3% on Tuesday noon to trade near a short-term level of resistance at $19.07. CRXl is a Zacks#1 Rank (“Strong buy”) stock. The average forecast for the company's 2009 profit has gone up to 80 cents per share from 41 cents in the last month.

"CRXL" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Amerisafe Inc (AMSF) Anaren Inc (ANEN) Biovail Corp (BVF) Blackrock Kelso Capital Corp (BKCC) Continucare Corp (CNU) Crucell NV (CRXL) Fairfax Financial Holdings Ltd (FFH) FalconStor Software Inc (FALC) Foster's Group Ltd (FBRWY) Horsehead Holding Corp (ZINC) i2 Technologies Inc (ITWO) Insulet Corp (PODD) Jazz Pharmaceuticals Inc (JAZZ) Kubota Corp (KUB) Medivation Inc (MDVN) Nash-Finch Co (NAFC) Orexigen Therapeutics Inc (OREX) PRIMEDIA Inc (PRM) Radiant Logistics Inc (RLGT) ResMed Inc (RMD) Skilled Healthcare Group Inc (SKH) Syniverse Holdings Inc (SVR) Triangle Petroleum Corp (TPLM) Veolia Environnement (VE) Wireless Ronin Technologies Inc (RNIN) Zurich Fincl Svcs (ZFSVF) View the entire Zacks #1 Rank List.

...